The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A

The effect of soy isoflavones on non-alcoholic fatty liver disease and the level of fibroblast growth factor-21 and fetuin A

Abstract A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive two tablets of soy isoflavone (100 mg/day) or placebo. At week 12, the serum levels of alanine amino transferas...

Full description

Bibliographic Details
Main Authors: Asal Neshatbini Tehrani, Behzad Hatami, Bizhan Helli, Zahra Yari, Ghazal Daftari, Amin Salehpour, Mehdi Hedayati, Elmira Khalili, Seyed Ahmad Hosseini, Azita Hekmatdoost
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-55747-6

Internet

https://doi.org/10.1038/s41598-024-55747-6

Similar Items